During the last session, BioNTech SE ADR (NASDAQ:BNTX)’s traded shares were 1.05 million, with the beta value of the company hitting 1.36. At the end of the trading day, the stock’s price was $92.80, reflecting an intraday loss of -2.05% or -$1.94. The 52-week high for the BNTX share is $131.49, that puts it down -41.69 from that peak though still a striking 17.53% gain since the share price plummeted to a 52-week low of $76.53. The company’s market capitalization is $22.31B, and the average trade volume was 1.10 million shares over the past three months.
BioNTech SE ADR (BNTX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. BNTX has a Sell rating from 2 analyst(s) out of 13 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 9 recommend a Buy rating for it.
BioNTech SE ADR (NASDAQ:BNTX) trade information
BioNTech SE ADR (BNTX) registered a -2.05% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.05% in intraday trading to $92.80, hitting a weekly high. The stock’s 5-day price performance is -10.90%, and it has moved by 6.89% in 30 days. Based on these gigs, the overall price performance for the year is 0.09%.
The consensus price target of analysts on Wall Street is $131, which implies an increase of 29.16% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $121 and $145 respectively. As a result, BNTX is trading at a discount of -56.25% off the target high and -30.39% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -25.87%. While earnings are projected to return -99.29% in 2025, the next five years will return -20.40% per annum.
BNTX Dividends
BioNTech SE ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.79 million shares, is of PRIMECAP MANAGEMENT CO/CA/’s that is approximately 1.9922% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $384.89 million.
Also, the Mutual Funds coming in first place with the largest holdings of BioNTech SE ADR (BNTX) shares are VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund and PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund . Data provided on Dec 31, 2024 indicates that VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund owns about 2.27 shares. This amounts to just over 0.95 percent of the company’s overall shares, with a $210.74 million market value. The same data shows that the other fund manager holds slightly less at 1.04, or about 0.44% of the stock, which is worth about $96.92 million.
